A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
about
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trialsClinical Trials in Branch Retinal Vein OcclusionSYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials.Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2.One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK.Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series.Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionReal-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa.Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion.“Off-label” use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients.Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2).Recent advances in understanding and managing retinal vein occlusions.Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.Update in the Management of Macular Edema Following Retinal Vein OcclusionsBaseline morphological characteristics as predictors of final visual acuity in patients with branch retinal vein occlusions: MARVEL report no. 3
P2860
Q26750459-F6C5D60A-D318-4D77-9613-90C4B504559CQ26767092-D4AAC2AA-DE43-4C77-B30F-77F90EE49256Q30490738-C86C8AC4-E32F-4FFC-99D5-5C5C42CC6518Q35769968-C86F1775-BFC3-4AEE-8C4F-469E8D92C319Q36058492-52DA8375-CC96-4008-BAFF-B826EA76C20BQ36111710-0C53BDAF-A876-4EEF-8F23-153ADD285F0CQ37530866-17864E6F-D2DA-4667-BF80-6546FF0B8C64Q38820906-A537D633-F318-4FBE-8FF7-75E1AE498982Q38848800-F0B072BD-2D4E-4422-824D-1D6513BAAD9BQ38896485-018A80C0-F7A7-4C6B-A5F9-4480B62A5F44Q40089995-A28F0588-D443-4179-8CE5-0DBC071722B0Q41371210-3FA81CBF-8026-484F-8E24-B7A111C8EFD8Q42204340-3DC63DF4-C089-45C0-BAC3-EED7D594F6B0Q47140209-C118B8DF-7F9B-47B7-91FC-ACE7CCDED4B5Q47399241-347F98DA-1863-4E7F-BAEA-0A5463C9412CQ47729194-A40244FE-C69C-4216-ADFD-ADE77A5C1BD2Q48352897-E7B46876-17C5-408B-80F7-24C42A9B6FB2Q49696877-10046006-24DC-4C3B-80E0-F455BF6AACA6Q52584491-CD80BA14-EFFD-415A-96D0-1AA015350434Q55283872-E360B679-D17F-427D-BC40-E699F54F1810Q55442786-AEB6E608-80C7-44B3-B07C-9F7104216C93Q57827814-DA3ADD58-0F9D-446A-A2B2-5066FBC68E77Q58777290-33BFE1A7-30A7-4110-8C25-E47B9B41DF09
P2860
A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@en
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@nl
type
label
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@en
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@nl
prefLabel
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@en
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@nl
P2093
P2860
P1476
A randomised, double-masked, c ...... cclusion: MARVEL Report No. 1.
@en
P2093
Jay Chhablani
M Hasnat Ali
MARVEL study group
Raja Narayanan
Subhadra Jalali
Taraprasad Das
P2860
P304
P356
10.1136/BJOPHTHALMOL-2014-306543
P407
P577
2015-01-28T00:00:00Z